Pure Global

The New Zealand Synergy Study for diabetes prevention in Asian Chinese - Trial ANZCTR12621000318886

Access comprehensive clinical trial information for ANZCTR12621000318886 through Pure Global AI's free database. This Not Applicable trial is sponsored by The University of Auckland and is currently Recruiting. The study focuses on Prediabetes.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Australian New Zealand Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
ANZCTR12621000318886
Not Applicable
Recruiting
other
Trial Details
Australian New Zealand Clinical Trials Registry โ€ข ANZCTR12621000318886
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
The New Zealand Synergy Study for diabetes prevention in Asian Chinese
The New Zealand Synergy Study: The effect of a dietary intervention on diabetes biomarkers in pre-diabetic Asian Chinese and European Caucasian cohorts

Study Focus

Prediabetes

Interventional

other

Sponsor & Location

The University of Auckland

New Zealand Ministry of Business, Innovation and Employment (MBIE) , National Science Challenge funding.

New Zealand

Timeline & Enrollment

Not Applicable

May 03, 2021

N/A

Primary Outcome

Change in plasma metabolome

Summary

Researchers aim to identify blood, urine and faecal markers of type 2 diabetes (T2D) risk that differ between ethnicities; and undertake nutritional interventions that target these biomarkers. Our previous study showed that Asian Chinese had a unique โ€˜fingerprintโ€™ of diabetes markers with worse blood glucose (blood sugar), lipids (blood fats), and different novel metabolomic markers when they were still younger and outwardly-slim than matched European Caucasian counterparts. The reason for this difference is not known, and so in this current study we will try to find out what causes the difference. One possibility is that the markers are different due to completely different home diets. Therefore, we will test whether differences in the novel โ€˜metabolomicsโ€™ blood markers are completely due to diet and also assess whether diet with additional nutrients may together (synergistically) be beneficial in changing the profile of these novel blood markers. In order to do so, we will design two healthy diets based on the New Zealand and the Chinese dietary guidelines for improving metabolic health. The two diet arms will be: 1) HEALTHY DIET (โ€˜controlโ€™ diet, HD): which adheres to NZ and Chinese national dietary guidelines for good metabolic health 2) HEALTHY SYNERGY+ DIET (SD): which adheres to NZ and Chinese national dietary guidelines for good metabolic health and includes some additional nutrients** hypothesised to have further improve metabolic health. ** Examples are whole foods such as omega-3 rich fish, more fibre, nuts and seeds, meat with less saturated fats. Both diets are healthy and matched with each other for energy content. All Caucasian participants will be enrolled in the Healthy diet arm while the Chinese participants will be allocated by chance to either the Healthy diet or the Healthy Synergy+ diet arms.

ICD-10 Classifications

Diabetes mellitus
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, unspecified
Other specified diabetes mellitus
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

Data Source

Australian New Zealand Clinical Trials Registry

ANZCTR12621000318886

Non-Device Trial